Process for the production of 2'-branched nucleosides

A technology of nucleosides and ester nucleosides, applied in the field of preparation of 2′-branched nucleosides, achieving simple purification steps, high yields, and short cycle times

Inactive Publication Date: 2006-03-08
IDENIX (CAYMAN) LTD
View PDF16 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, Borretzen et al. did not use the term "prodrug"

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for the production of 2'-branched nucleosides
  • Process for the production of 2'-branched nucleosides
  • Process for the production of 2'-branched nucleosides

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0157] Preparation of ribonolactones

[0158]

[0159] Ribonolactones can be prepared by any published or unpublished method, including standard oxidation and substitution techniques. One embodiment of the ribonolactone synthesis of the present invention is through D-fructose, according to the following steps.

[0160] Ribonolactone can be prepared by the reaction of D-fructose with calcium oxide (CaO). D-fructose can react with CaO in any molar ratio provided that the reaction proceeds at an acceptable rate without excessive by-products. For D-fructose, the preferred molar ratio is 5:1, and the more preferred molar ratio is 3:1, the most preferred molar ratio is 2.3:1.3. The CaO can be added at any rate provided that the reaction proceeds at an acceptable rate without generating excess heat or excessive by-products. In one embodiment, CaO is added incrementally over 5 minutes at room temperature. The reaction can be carried out until the D-fructose is almost consumed, ...

Embodiment approach

[0199] One embodiment of the invention includes a method of synthesizing the 3'-esters of β-D-2'-C-methyl-cytidine, in particular the following 3'-esters of β-D-2'-C-methyl-cytidine '-valine ester method.

[0200] The 3'-ester of β-D-2'-C-methyl-cytidine can be prepared by optionally protecting the amino group of β-D-2'-C-methyl-cytidine by any known method. For example in Greene, et al., Protective Groups in Organic Synthesis , the method taught in John Wiley and Sons, Second Edition, 1991. In one embodiment of the invention, β-D-2'-C-methyl-cytidine can be combined with Me 2 NCH(OMe) 2 Reaction in DMF yields N[1-(3,4-dihydroxy-5-hydroxymethyl-3-methyl-tetrahydrofuran-2-yl)-2-oxo-1,2-dihydro-pyrimidine-4 -yl]-N,N-dimethylformamidine.

[0201] In a specific embodiment, the compound can be further protected with TBDPSCl and imidazole to provide the 5'-silyl-protected compound, N'-{1-[5-(tert-butyl-diphenyl-silyloxy methyl)-3,4-dihydroxy-3-methyl-tetrahydrofuran-2-yl]-2...

Embodiment 1

[0223] 2-C-Methyl-D-ribo-γ-lactone

[0224] In a 250 mL 3-neck round bottom flask equipped with an overhead stirrer, stirrer shaft, digital temperature readout, and argon passage, stir deionized water (100 mL). Argon was bubbled through for 30 minutes, D-fructose (20.0 g, 0.111 mol) was added and the solution became clear within a few minutes. Calcium oxide (12.5 g, 0.223 mol) was added in portions over 5 minutes and the mixture was stirred vigorously. An exotherm was observed and the reaction temperature rose to 39.6°C after 10 minutes from the addition of calcium oxide. After about 15 minutes, the reaction mixture turned yellow and darkened with time. After 3 hours, a portion of the reaction mixture was removed for TLC analysis. The removed fraction was acidified to pH 2 with saturated aqueous oxalic acid. The resulting white suspension was distilled off of water under reduced pressure. Toluene (2 mL) was added to the residue, and the mixture was distilled under reduced...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
melting pointaaaaaaaaaa
Login to view more

Abstract

The present invention provides an improved process for preparing ss-D and ss-L 2'-C-methyl-nucleosides and 2'-C-methyl-3'-O-ester nucleosides.

Description

[0001] cross reference [0002] This application claims priority to US Patent Application No. 60 / 432,766, filed December 12, 2002, and US Patent Application No. 60 / 466,194, filed April 28, 2003. technical field [0003] The present invention relates to a process for the preparation of sugar-like compounds having protected oxygen substituents, in particular 2,3,5-(independently optionally protected hydroxy)-2-C-methyl-β-D-ribofuranose and 2 , The preparation method of 3,5-(independent optionally protected hydroxy)-2-C-methyl-D-ribonic acid-γ-lactone. The present invention also includes processes for the preparation of nucleosides, in particular 3',5'-(independently optionally protected hydroxy)-2'-C-methyl- The method of β-D-cytidine, in particular, relates to the synthesis of precursors of pharmaceutical compounds. More specifically, the present invention describes the synthesis of prodrugs for administration of antiviral nucleoside and nucleoside a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7072C07H19/067
CPCY02A50/30
Inventor 理查德·斯托勒阿德尔·穆萨纳拉扬·乔杜里弗兰克·瓦利戈拉
Owner IDENIX (CAYMAN) LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products